Explore All 191 Merger Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 4, 2012 |
| Target | ANI Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | ANI Pharmaceuticals |
| Deal Type | Merger |
| Advisor(s) | SNR Denton LLP (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2001 |
| Sector | Life Science |
| Employees | 897 |
| Revenue | 614M USD (2024) |
ANI Pharmaceuticals is a developer, manufacturer, and marketer of top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI Pharmaceuticals was founded in 2001 and is based in Baudette, Minnesota.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 15 |
| Sector: Life Science | 2 of 13 |
| Type: Merger | 1 of 2 |
| State: Minnesota | 2 of 2 |
| Country: United States | 2 of 12 |
| Year: 2012 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-05-07 |
Solvay Pharmaceuticals - Rx Facilities
Baudette, Minnesota, United States Solvay Pharmaceuticals - Rx Facilities plants add 173,000 sq. ft. of manufacturing and laboratory capacity, substantially expanding capabilities and enhancing its already-rapid growth. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-26 |
Teva Pharmaceutical - 31 Generic Drug Products
United States Teva Pharmaceutical - 31 Generic Drug Products includes 20 solid-oral immediate release products, 4 extended release products and 7 liquid products. |
Buy | $13M |
